Picture of Tomocube logo

475960 Tomocube Income Statement

0.000.00%
kr flag iconLast trade - 00:00
HealthcareHighly SpeculativeSmall CapNeutral

Annual income statement for Tomocube, fiscal year end - December 31st, KRW millions except per share, conversion factor applied.

2021
December 31st
2022
December 31st
2023
December 31st
2024
December 31st
Period Length:12 M12 M12 M12 M
Source:PROSPECTUSPROSPECTUSPROSPECTUSAnnual Audited Accounts
Standards:
IFRS
IFRS
IFRS
IFRS
Status:FinalFinalFinalFinal
Revenue
Total Revenue1,6251,8713,7475,939
Cost of Revenue
Gross Profit6669432,1823,590
Selling / General / Administrative Expenses
Research And Development
Depreciation and Amortization
Unusual Expense / Income
Total Operating Expenses8,0358,24010,47314,718
Operating Profit-6,410-6,369-6,726-8,780
Gain / Loss on Sale of Assets
Total Net Non Operating Interest Income / Expense
Other Net Non Operating Costs
Net Income Before Taxes-19,34929,336-23,550-8,302
Provision for Income Taxes
Net Income After Taxes-19,34929,336-23,550-8,302
Net Income Before Extraordinary Items
Net Income-19,34929,336-23,550-8,302
Income Available to Common Shareholders Excluding Extraordinary Items
Income Available to Common Shareholders Including Extraordinary Items
Diluted Net Income-19,34929,336-23,550-8,302
Diluted Weighted Average Shares
Basic EPS Including Extraordinary Items
Diluted EPS Including Extraordinary Items
Diluted EPS Excluding Extraordinary Items
Normalised Income Before Taxes
Normalised Income After Taxes
Normalised Income Available to Common Shareholders
Diluted Normalised EPS-1,5202,304-1,850-754
Dividends per Share